Methotrexate twice weekly vs once weekly in rheumatoid arthritis: A pilot double-blind, controlled study

Rheumatology International

Volumn 22, Issue 1, 2002, Pages 1-4

  Pandya, Sapan ^a   Aggarwal, Amita ^a   Misra, Ramnath ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DMARDs; Hepatotoxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; METHOTREXATE; ANTIRHEUMATIC AGENT;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; LABORATORY TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; ARTHRALGIA; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; PAIN ASSESSMENT; PATHOPHYSIOLOGY;

ANTIRHEUMATIC AGENTS; ARTHRALGIA; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; METHOTREXATE; PAIN MEASUREMENT; PILOT PROJECTS; TREATMENT OUTCOME; HUMANS;

EID: 0035985543     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0186-y     Document Type: Article

References (22)

1. Methotrexate therapy in rheumatoid arthritis: 15 years' experience
2. Methotrexate: A perspective of its use in the treatment of rheumatic diseases
3. Low dose methotrexate in rheumatoid arthritis
4. A long term prospective study of the use of methotrexate in rheumatoid arthritis
5. Polyglutamation of methotrexate: Is methotrexate a prodrug?
6. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: Association of hepatic folate deficiency and formation of polyglutamates
7. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells
8. Inhibition of phophoribosylaminoimidazole carboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates
9. Inhibition of 5-aminoiminadazole 4-carboxamideribotide transformylase, adenosine deaminase and 5'adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole 4-carboxamideriboside and ribotide
10. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
11. Consensus statement on the initiation and continuation of TNF blocking therapies in RA
12. Modified disease activity scores that include 28 joint counts
13. ACR preliminary definition of improvement in rheumatoid arthritis
14. Function and health related quality of life. Results from a randomised controlled trial of leflunomide vs methotrexate or placebo in patients with active rheumatoid arthritis
15. Should improvement in rheumatoid arthritis clinical trials be defined as 50% or 70% improvement in core set measures rather than 20%?
16. Every other week methotrexate in patients with rheumatoid arthritis
17. Methotrexate treatment of RA. Is a fortnightly maintenance schedule enough?
18. Treatment of rheumatoid arthritis with methotrexate: A prospective open long term study of 191 cases
19. The mechanism of action of methotrexate
20. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells: Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate to dihydrofolate reductase
21. Methotrexate hepatotoxicity in psoriasis - Comparison of different dose regimens